HealthEquity (NASDAQ:HQY) Sets New 1-Year High – Still a Buy?

Shares of HealthEquity, Inc. (NASDAQ:HQY) hit a new 52-week high on Wednesday . The stock traded as high as $113.90 and last traded at $112.97, with a volume of 164646 shares trading hands. The stock had previously closed at $112.50.

Wall Street Analyst Weigh In

HQY has been the topic of a number of recent analyst reports. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Barrington Research lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Bank of America upped their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Trading Up 1.0 %

The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $9.84 billion, a P/E ratio of 104.47, a P/E/G ratio of 1.61 and a beta of 0.55. The firm’s 50-day moving average price is $101.40 and its 200 day moving average price is $90.20.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the business earned $0.40 EPS. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Hedge funds have recently made changes to their positions in the company. Wealthfront Advisers LLC purchased a new position in HealthEquity in the 4th quarter valued at approximately $10,304,089,000. Vanguard Group Inc. grew its position in shares of HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after purchasing an additional 99,624 shares in the last quarter. Wasatch Advisors LP grew its position in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares in the last quarter. State Street Corp raised its stake in shares of HealthEquity by 0.8% during the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after purchasing an additional 23,613 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after purchasing an additional 15,145 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.